Adam C. Ehrlich, MD, MPH, Interim Chief of the Section of Gastroenterology and Hepatology at the Lewis Katz School of Medicine at Temple University and Medical Director of the Inflammatory Bowel Disease (IBD) Program at Temple University Hospital, provided perspective to HealthCentral on a new Gastroenterology paper that makes the case for de-intensifying therapy for people with IBD.
800-TEMPLE-MED
Schedule Appointment
SEARCH TEMPLE HEALTH